Basic Information
RNALocate ID: | RLID:11002591 |
RNA Symbol: | hsa-miR-342-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-342-3p |
RNA ID: | miRBase:MIMAT0000753 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 24009880 |
Tissue/Cell Line: | Human mast cell line (HMC-1) |
Method: | Microarray |
Description: | In the exosomes, 116 microRNAs were identified and 134 microRNAs were identified in the donor HMC-1 cells (Fig. 3a and 3b, Table I and Additional Information, Table S16). Data are collected from Table 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002053 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002054 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002055 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002056 | Nucleolus | HeLa cells | 23940654 |
RLID:01002057 | Nucleolus | Breast adenocarcinoma cells (MCF-7) | 24918059 |
RLID:01002058 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11002584 | Exosome | Serum | 18589210 |
RLID:11002585 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11002586 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11002587 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002588 | Exosome | Renal cancer cells | 21670082 |
RLID:11002589 | Exosome | Brain tissue | 23382797 |
RLID:11002590 | Exosome | Plasma | 23663360 |
RLID:11002592 | Exosome | Serum | 25349172 |
RLID:11002593 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11002594 | Microvesicle | Seminal plasma | 23539611 |
RLID:11002595 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000129 | Exosome | B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Mast cells|Seminal fluid | |
RLID-D:11000430 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-342-3p | Diffuse large b cell lymphoma | MNDR-E-MI-42082 |
MNDR | hsa-miR-342-3p | Splenic marginal zone lymphoma | MNDR-E-MI-42083 |
MNDR | hsa-miR-342-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-42084 |
MNDR | hsa-miR-342-3p | Oral squamous cell carcinoma | MNDR-E-MI-42085 |
MNDR | hsa-miR-342-3p | B cell lymphoma of malt type | MNDR-E-MI-42086 |
MNDR | hsa-miR-342-3p | Lymphoma | MNDR-E-MI-42087 |
MNDR | hsa-miR-342-3p | Lymphoma non-hodgkin | MNDR-E-MI-42088 |
MNDR | hsa-miR-342-3p | Cutaneous t cell lymphoma | MNDR-E-MI-42089 |
MNDR | hsa-miR-342-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-42090 |
MNDR | hsa-miR-342-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-42091 |
MNDR | hsa-miR-342-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-42092 |
MNDR | hsa-miR-342-3p | Acute promyelocytic leukemia | MNDR-E-MI-42093 |
MNDR | hsa-miR-342-3p | Breast cancer luminal | MNDR-E-MI-42094 |
MNDR | hsa-miR-342-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-42095 |
MNDR | hsa-miR-342-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-42096 |
MNDR | hsa-miR-342-3p | Prostate cancer | MNDR-E-MI-42097 |
MNDR | hsa-miR-342-3p | Gastric cancer | MNDR-E-MI-42098 |
MNDR | hsa-miR-342-3p | Gastric lymphoma | MNDR-E-MI-42099 |
MNDR | hsa-miR-342-3p | Alzheimer disease | MNDR-E-MI-42100 |
MNDR | hsa-miR-342-3p | Intracranial aneurysm | MNDR-E-MI-42101 |
MNDR | hsa-miR-342-3p | Dysautonomia familial | MNDR-E-MI-42102 |
MNDR | hsa-miR-342-3p | Head and neck cancer | MNDR-E-MI-42103 |
MNDR | hsa-miR-342-3p | Leukemia | MNDR-E-MI-42104 |
MNDR | hsa-miR-342-3p | Huntington disease | MNDR-E-MI-42105 |
MNDR | hsa-miR-342-3p | Chorea | MNDR-E-MI-42106 |
MNDR | hsa-miR-342-3p | Cardiovascular disease | MNDR-E-MI-42107 |
MNDR | hsa-miR-342-3p | Neurodegenerative diseases | MNDR-E-MI-42108 |
MNDR | hsa-miR-342-3p | Lung cancer | MNDR-E-MI-42109 |
MNDR | hsa-miR-342-3p | Parkinson disease | MNDR-E-MI-42110 |
MNDR | hsa-miR-342-3p | Machado-joseph disease | MNDR-E-MI-42111 |
MNDR | hsa-miR-342-3p | Breast cancer | MNDR-E-MI-42112 |
MNDR | hsa-miR-342-3p | Pancreatic cancer | MNDR-E-MI-42113 |
MNDR | hsa-miR-342-3p | Rectum adenocarcinoma | MNDR-E-MI-42114 |
MNDR | hsa-miR-342-3p | Nephroblastoma | MNDR-E-MI-42115 |
MNDR | hsa-miR-342-3p | Colon cancer | MNDR-E-MI-42116 |
MNDR | hsa-miR-342-3p | Colon adenocarcinoma | MNDR-E-MI-42117 |
MNDR | hsa-miR-342-3p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-42118 |
MNDR | hsa-miR-342-3p | Familial ovarian cancer | MNDR-E-MI-42119 |
MNDR | hsa-miR-342-3p | Prostate adenocarcinoma | MNDR-E-MI-42120 |
MNDR | hsa-miR-342-3p | Kidney cancer | MNDR-E-MI-42121 |
MNDR | hsa-miR-342-3p | Carcinoma ductal breast | MNDR-E-MI-42122 |
MNDR | hsa-miR-342-3p | Glioblastoma | MNDR-E-MI-42123 |
MNDR | hsa-miR-342-3p | Glioma | MNDR-E-MI-42124 |
MNDR | hsa-miR-342-3p | Chordoma | MNDR-E-MI-42125 |
MNDR | hsa-miR-342-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-42126 |
MNDR | hsa-miR-342-3p | Osteosarcoma | MNDR-E-MI-42127 |
MNDR | hsa-miR-342-3p | Breast carcinoma | MNDR-E-MI-42128 |
MNDR | hsa-miR-342-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-42129 |
MNDR | hsa-miR-342-3p | Meningioma | MNDR-E-MI-42130 |
MNDR | hsa-miR-342-3p | Liver cancer | MNDR-E-MI-42131 |
MNDR | hsa-miR-342-3p | Gastric adenocarcinoma | MNDR-E-MI-42132 |
MNDR | hsa-miR-342-3p | Lung squamous cell carcinoma | MNDR-E-MI-42133 |
MNDR | hsa-miR-342-3p | Carcinoma lung non-small-cell | MNDR-E-MI-42134 |
MNDR | hsa-miR-342-3p | Lung adenocarcinoma | MNDR-E-MI-42135 |
MNDR | hsa-miR-342-3p | Thyroid carcinoma | MNDR-E-MI-42136 |
MNDR | hsa-miR-342-3p | Cervical cancer | MNDR-E-MI-42137 |
MNDR | hsa-miR-342-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-42138 |
MNDR | hsa-miR-342-3p | Carcinoma renal cell | MNDR-E-MI-42139 |
MNDR | hsa-miR-342-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-42140 |
MNDR | hsa-miR-342-3p | Clear cell renal cell carcinoma | MNDR-E-MI-42141 |
MNDR | hsa-miR-342-3p | Cholangiocarcinoma | MNDR-E-MI-42142 |
MNDR | hsa-miR-342-3p | Lung small cell carcinoma | MNDR-E-MI-42143 |
MNDR | hsa-miR-342-3p | Variant creutzfeldt-jakob disease | MNDR-E-MI-42144 |
MNDR | hsa-miR-342-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-42145 |
MNDR | hsa-miR-342-3p | T acute lymphoblastic leukemia | MNDR-E-MI-42146 |
MNDR | hsa-miR-342-3p | Acute t cell leukemia | MNDR-E-MI-42147 |
MNDR | hsa-miR-342-3p | Prion disease | MNDR-E-MI-42148 |
MNDR | hsa-miR-342-3p | Breast invasive carcinoma | MNDR-E-MI-42149 |
MNDR | hsa-miR-342-3p | Hepatocellular carcinoma | MNDR-E-MI-42150 |
MNDR | hsa-miR-342-3p | Familiar ovarian carcinoma | MNDR-E-MI-42151 |
MNDR | hsa-miR-342-3p | B-cell lymphoma | MNDR-E-MI-42152 |
MNDR | hsa-miR-342-3p | Rheumatoid arthritis | MNDR-E-MI-42153 |
MNDR | hsa-miR-342-3p | T-cell leukemia | MNDR-E-MI-42154 |
MNDR | hsa-miR-342-3p | Malignant pleural mesothelioma | MNDR-E-MI-42155 |
MNDR | hsa-miR-342-3p | Retinoblastoma | MNDR-E-MI-42156 |
MNDR | hsa-miR-342-3p | Neuroblastoma | MNDR-E-MI-42157 |
MNDR | hsa-miR-342-3p | Hodgkin lymphoma | MNDR-E-MI-42158 |
MNDR | hsa-miR-342-3p | Burkitt lymphoma | MNDR-E-MI-42159 |
MNDR | hsa-miR-342-3p | Tonsil cancer | MNDR-E-MI-42160 |
MNDR | hsa-miR-342-3p | Neuromyelitis optica | MNDR-E-MI-42161 |
MNDR | hsa-miR-342-3p | Skin cutaneous melanoma | MNDR-E-MI-42162 |
MNDR | hsa-miR-342-3p | Skin melanoma | MNDR-E-MI-42163 |
MNDR | hsa-miR-342-3p | Colorectal cancer | MNDR-E-MI-42164 |
MNDR | hsa-miR-342-3p | Nasopharynx carcinoma | MNDR-E-MI-42165 |
MNDR | hsa-miR-342-3p | Multiple myeloma | MNDR-E-MI-42166 |
MNDR | hsa-miR-342-3p | Uterine cervical neoplasms | MNDR-E-MI-42167 |
MNDR | hsa-miR-342-3p | Nasopharyngeal cancer | MNDR-E-MI-42168 |
MNDR | hsa-miR-342-3p | Prostatic neoplasms | MNDR-E-MI-42169 |
MNDR | hsa-miR-342-3p | Sleep deprivation | MNDR-E-MI-42170 |
MNDR | hsa-miR-342-3p | Epstein-barr virus infections | MNDR-E-MI-42171 |
MNDR | hsa-miR-342-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-42172 |
MNDR | hsa-miR-342-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-42173 |
MNDR | hsa-miR-342-3p | Stroke lacunar | MNDR-E-MI-42174 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ANKRD49 | Homo sapiens | RR00081534 |
TOP